Lofexidine, the first medication for use in reducing symptoms associated with opioid withdrawal in adults, has been approved by the U.S. Food and Drug Administration. Lofexidine, an oral tablet, is designed to manage the symptoms patients often experience during opioid discontinuation.
Barriers to Getting Substance Abuse Treatment
Alcohol-Related Cirrhosis More Serious
Poverty, Stress a Factor in Overdose Deaths
Drinking Alcohol Biggest Risk for Dementia
Alcohol use disorders are the most important preventable risk factors for the onset of all types of dementia, especially early-onset dementia. This according to a nationwide observational study, published in The Lancet Public Health journal, of over one million adults diagnosed with dementia in France.
Alcoholism 'Wonder Drug' Is a Dud
A drug used to treat spasticity was touted as a 'wonder drug' for alcohol use disorders, but researchers found it is no more effective than a placebo for reducing alcohol consumption and alcohol cravings.
Long-Term Recovery Increases Quality of Life
Receiving successful treatment for an alcohol and drug problem can result in steep increases in physical, psychological, and social well-being, according to the Research Society on Alcoholism.
Follow-Up Increases Naltrexone Compliance
Symptoms of alcoholism make it more difficult for some people to regularly take the prescription drug naltrexone, which could help treat their disease, a researcher at Oregon State University has found.